ZoomRx

AAN 2025: Navigating the Future of Neurological Care Explore key takeaways from AAN 2025, including updates in Alzheimer’s, MS, myasthenia gravis, and more. Discover emerging therapies, physician insights, and more.

At AAN 2025, neurologists explored GLP-1s for Alzheimer’s, biologics for MG, new MS insights, and more—but also asked: What’s actually ready for practice?🧠
Real insights from the frontlines.
blog.zoomrx.com/hcp-communit...
#AAN2025 #Neurology #brainhealth #Alzheimers #MS #NeuroTech #Neuroscience

29.04.2025 13:41 — 👍 0    🔁 0    💬 0    📌 0

Oncology Insights 2025: AACR Conference Highlights & Upcoming Trends

Calling all Oncologists and Healthcare Professionals!

Discover the one-stop hub for all your AACR needs: aacr.zoomrx.com

Simplify how you access critical cancer research and stay informed on the latest advances. #AACR #Oncology #CancerResearch #HCP #AACR2025

26.04.2025 14:43 — 👍 0    🔁 0    💬 0    📌 0

Which AACR 2025 topic do you predict will have the biggest clinical impact?
1. Clinical Trials (KEYNOTE-689, PETRA)
2. Immunotherapy (CAR T-cell)
3. Precision Oncology (ctDNA, AI)
4. Radiotherapy (Flash RT).
Join the #AACR Insights Challenge! #Oncology #Cancer #MedEd #MedOnc #MedNews #AACR

24.04.2025 15:34 — 👍 0    🔁 0    💬 0    📌 0

🔬 Exciting insights from our Panel of Expert Oncologists! They expect ADCs (48%) to drive metastatic breast cancer survival by 2030, followed by next-gen therapies (26%), CDK4/6 inhibitors (17%), and cellular therapies (9%). What’s your take? Share your views! #Oncology #BreastCancer #MedEd

11.04.2025 09:15 — 👍 0    🔁 0    💬 0    📌 0

Summary of key findings from AACR 2025

#NSCLC research from #AACR2025 for oncologists: SGI-1027 + osimertinib overcomes EGFR resistance. Ramucirumab combo improves PFS in Phase II RAMOSE trial. KRASG12C oxidation state impacts inhibitor efficacy.

Full analysis: blog.zoomrx.com/ferma-congre... #Oncology #CancerResearch #LungCancer

04.04.2025 13:19 — 👍 3    🔁 0    💬 0    📌 0

FDA Approvals Mar 24 - 30, 2025

What a week for oncology and hematology! 🚀 4 FDA approvals. We've broken down the key details. What's catching your eye? What do these approvals mean for your practice? #MedBsky #MedSky #MedBluesky

31.03.2025 14:09 — 👍 2    🔁 0    💬 0    📌 0

Turn your conference knowledge into monetary rewards. Join the ZoomRx Panel Today! app.zoomrx.com#/user/signup #ACC2025 #SSO2025 #ACC25 #SSO25 #PaidSurveys #SurgicalOncology #Cardiology

29.03.2025 15:08 — 👍 0    🔁 0    💬 0    📌 0

Attention US Physicians: Get paid instantly for your clinical expertise. Share your insights through relevant surveys by joining our Panel - quick verification, instant payment, and flexible participation. Sign up today: app.zoomrx.com/#/user/signup #MedBsky #MedSky #MedBluesky #PaidSurveys

28.03.2025 12:20 — 👍 0    🔁 0    💬 0    📌 0

Themes that will impact the oncology care in the next 5 years

What will shape the future of oncology care? Our expert panel of oncologists says personalized medicine (37%), AI/ML in treatment planning (28%) & immunotherapy (28%) are key. Your voice matters. Join our community of HCPs to shape the future of medicine: app.zoomrx.com#/user/signup #MedBsky #MedSky

26.03.2025 08:09 — 👍 1    🔁 0    💬 0    📌 0

ZoomRx: Market Research Reimagined

Hey! I’ve had a great experience with ZoomRx market research studies. You can get paid for quick, tailored surveys. If you’re a healthcare professional , join using this link: refer.zoomrx.com/jenniferg661...

21.02.2025 13:36 — 👍 2    🔁 1    💬 0    📌 0

In an AI-dominated world, physician expertise, not algorithms, drives patient outcomes. Be a part of ZoomRx's HCP panel to shape treatments, get paid instantly, and access cutting-edge insights in your field. Click to register now: app.zoomrx.com#/user/signup #MedBsky #MedSky

18.03.2025 17:50 — 👍 1    🔁 0    💬 0    📌 0